Norepinephrine use at extubation in critically ill patients with obesity: a cohort study with multicenter validation
- PMID: 40768069
- DOI: 10.1007/s00134-025-08066-x
Norepinephrine use at extubation in critically ill patients with obesity: a cohort study with multicenter validation
Abstract
Purpose: The aim of this study was to assess whether norepinephrine at the time of extubation increases reintubation rates in critically ill patients with obesity.
Methods: The initial step was to analyze data that had been collected prospectively, using a retrospective approach-defined as the main cohort. Then, we validated our findings using data from a multicenter randomized-controlled trial (validation cohort). The primary objective was to compare reintubation within 7 days, between patients with norepinephrine and without norepinephrine at the time of extubation. The secondary objective was to assess norepinephrine doses at extubation, normalized to body weight.
Results: Among the 3186 patients included in the main cohort, 837 had obesity. Among them, 213 (25%) were extubated with norepinephrine, with a median norepinephrine dose at extubation of 0.6 mg/h of absolute value which corresponds to 0.097 (0.04-0.17) µg/kg/min of real body weight. No significant difference in reintubation rates was observed between patients extubated with norepinephrine (16%) and those without (17%, p = 0.85). Among the 656 patients with obesity in the validation cohort, we observed similar results, with a reintubation rate of 18% in those extubated with norepinephrine and 15% in those without (p = 0.45). Similar results were observed in the 2349 patients without obesity.
Interpretation: In critically ill patients with obesity, the use of norepinephrine at the time of extubation did not significantly increase the reintubation rates.
Clinical trial registration: NCT04014920 for the validation cohort.
Keywords: Critical care; Extubation failure; ICU; Intensive care unit; Norepinephrine; Obesity; Vasopressors; Weaning.
© 2025. Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Conflicts of interest: Pr. Jaber reports receiving consulting fees from Drager, Medtronic, Fresenius, Baxter, Mindray, and Fisher & Paykel. Pr De Jong reports receiving payments for presentations for Drager, Medtronic, Viatris, Mindray, and Fisher & Paykel. No potential conflicts of interest relevant to this article were reported for the other authors. Pr. Jaber is the Editor in Chief of Intensive Care Medicine. He has not taken part in the review or selection process of this article. Ethics committee approval: We obtained the approval from the ethic committee (Comité Local d’Ethique de la Recherche, agreement number: 198711) of the Montpellier University Hospital. The need for informed consent was waived.
Similar articles
-
Cough augmentation techniques for extubation or weaning critically ill patients from mechanical ventilation.Cochrane Database Syst Rev. 2017 Jan 11;1(1):CD011833. doi: 10.1002/14651858.CD011833.pub2. Cochrane Database Syst Rev. 2017. PMID: 28075489 Free PMC article.
-
Sertindole for schizophrenia.Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article.
-
Automated weaning and SBT systems versus non-automated weaning strategies for weaning time in invasively ventilated critically ill adults.Cochrane Database Syst Rev. 2014 Sep 9;2014(9):CD008638. doi: 10.1002/14651858.CD008638.pub2. Cochrane Database Syst Rev. 2014. PMID: 25203308 Free PMC article.
-
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599. Online ahead of print. Clin Orthop Relat Res. 2025. PMID: 40569278
-
Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients.Cochrane Database Syst Rev. 2015 Jan 8;1(1):CD010225. doi: 10.1002/14651858.CD010225.pub2. Cochrane Database Syst Rev. 2015. PMID: 25568981 Free PMC article.
References
-
- Thille AW, Richard JC, Brochard L (2013) The decision to extubate in the intensive care unit. Am J Respir Crit Care Med 187:1294–1302 - PubMed
-
- Godet T, Chabanne R, Marin J, Kauffmann S, Futier E, Pereira B, Constantin JM (2017) Extubation failure in brain-injured patients: risk factors and development of a prediction score in a preliminary prospective cohort study. Anesthesiology 126:104–114 - PubMed
-
- Quintard H, l’Her E, Pottecher J, Adnet F, Constantin J-M, De Jong A, Diemunsch P, Fesseau R, Freynet A, Girault C (2019) Experts’ guidelines of intubation and extubation of the ICU patient of French Society of Anaesthesia and Intensive Care Medicine (SFAR) and French-speaking Intensive Care Society (SRLF). Ann Intensive Care 9:1–7
-
- Boles JM, Bion J, Connors A, Herridge M, Marsh B, Melot C, Pearl R, Silverman H, Stanchina M, Vieillard-Baron A, Welte T (2007) Weaning from mechanical ventilation. Eur Respir J 29:1033–1056 - PubMed
Associated data
LinkOut - more resources
Full Text Sources
Medical